Sudafed PE

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Vicks
gptkbp:approves gptkb:2000
gptkbp:brand gptkb:Sudafed_PE
gptkbp:class decongestant
gptkbp:clinical_trial studied for efficacy
studied for safety
studied for side effects
gptkbp:contraindication hypertension
MAO inhibitors
severe coronary artery disease
gptkbp:dosage_form oral
gptkbp:form gptkb:tablet
gptkb:item
gptkbp:has_ability 10 mg
15 mg
30 mg
https://www.w3.org/2000/01/rdf-schema#label Sudafed PE
gptkbp:indication cold symptoms
sinus pressure
allergy symptoms
gptkbp:ingredients gptkb:phenylephrine
gptkbp:interacts_with other stimulants
blood pressure medications
certain antidepressants
gptkbp:is_available_on gptkb:drug
gptkbp:is_used_for relief of nasal congestion
gptkbp:legal_issue OTC
gptkbp:manager oral
gptkbp:manufacturer gptkb:Johnson_&_Johnson
gptkbp:packaging gptkb:beer
blister pack
gptkbp:population adults
children over 12
gptkbp:related_to gptkb:Sudafed
gptkbp:shelf_life varies by manufacturer
gptkbp:side_effect dizziness
nausea
vomiting
restlessness
insomnia
dry mouth
nervousness
rapid heartbeat
increased blood pressure
gptkbp:storage room temperature
gptkbp:suitable_for pregnant women
people with certain medical conditions
nursing mothers
children under 4